Status: Recruiting
Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical Centers
Multicenter observational study to explore the efficacy of ActiGraft in the treatment of exuding cutaneous wounds in real-life usage.
Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: RedDress Ltd.Updated: Jul 29, 2025Locations: 1Duration: 1 Year
Eligibility criteria
Subject is ≥18 years of age [+3]
Subject/LAR is unable to read and understand English or Spanish.